KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
================================================================================================================================================================================

* Amy K Erbe
* Mitch B Diccianni
* Rajen Mody
* Arlene Naranjo
* Fan F Zhang
* Jen Birstler
* KyungMann Kim
* Arika S Feils
* Jung-Tung Hung
* Wendy B London
* Barry L Shulkin
* Varsha Mathew
* Marguerite T Parisi
* Sabah Servaes
* Shahab Asgharzadeh
* John M Maris
* Julie Park
* Alice L Yu
* Paul M Sondel
* Rochelle Bagatell